Chen Yiru, Cao Buzi, Zhou Quan, Liu Yantong, He Qingnan, Zhao Mingyi
Department of Pediatrics, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.
Xiangya School of Medicine, Central South University, Changsha, China.
Front Cardiovasc Med. 2023 Jan 13;9:1070336. doi: 10.3389/fcvm.2022.1070336. eCollection 2022.
This study aimed to investigate the international scientific output regarding the relationship between COVID-19 and cardiovascular diseases (CVDs) through a bibliometric analysis and explore research hotspots in this field.
We searched the Web of Science Core Collection for publications and used different types of software, such as R, CiteSpace, and VOSviewer, to analyze and visualize the data.
A total of 10,055 publications were retrieved as of the 13 December 2022, based on the inclusion criteria after screening. The USA and China lead in the quantity and quality of publications in this field. Based on Bradford's law, 63 journals were considered core journals in the field. Co-cited references and keywords analysis indicated that researchers paid particular attention to cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. In summary, with increasing COVID-19 research related to CVD, more attention might be drawn to the relationship between these two diseases.
The hotspots in this field may continue to revolve around cardiovascular comorbidities, outcomes, and COVID-19 regenerative medicine. Owing to the different situations faced by different groups with COVID-19, further exploration of the related factors specific to each of these groups, e.g., history or no history of heart failure, is needed, with a view to providing a reference for intervention measures in COVID-19 research.
本研究旨在通过文献计量分析调查关于2019冠状病毒病（COVID-19）与心血管疾病（CVDs）之间关系的国际科学产出，并探索该领域的研究热点。
我们在科学网核心合集（Web of Science Core Collection）中检索出版物，并使用不同类型的软件，如R、CiteSpace和VOSviewer，来分析和可视化数据。
截至2022年12月13日，根据筛选后的纳入标准，共检索到10,055篇出版物。美国和中国在该领域的出版物数量和质量方面领先。根据布拉德福定律，63种期刊被认为是该领域的核心期刊。共被引参考文献和关键词分析表明，研究人员特别关注心血管合并症、结局以及COVID-19再生医学。总之，随着与CVD相关的COVID-19研究不断增加，这两种疾病之间的关系可能会受到更多关注。
该领域的热点可能会继续围绕心血管合并症、结局以及COVID-19再生医学。由于不同的COVID-19群体面临不同的情况，需要进一步探索这些群体各自特有的相关因素，例如有无心力衰竭病史，以便为COVID-19研究中的干预措施提供参考。
